Xiuxia Liu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Xiuxia Liu

Showing results (131-140 of 133) with videos related to

Pageof 14

Sort By:

You have reached the last page of results.This site can display upto 133 results.

JCI Insight|May 19, 2026

Derivation and characterization of ubiquitin-specific protease 18 inhibitorsBlessing O Ogunlade, Kevin N Dalby, Samuel C Okpechi, et al.

Scientific Reports|September 9, 2023

A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironmentCheng-Hsin Wei, Lu Huang, Blair Kreh, et al.

Molecular Cancer Therapeutics|December 5, 2020

A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid CancersMasanori Kawakami, Lisa Maria Mustachio, Yulong Chen, et al.

Pageof 14

Search research articles

Showing results (131-140 of 133) with videos related to

Sort By:

Pageof 14

You have reached the last page of results.This site can display upto 133 results.

JCI Insight|May 19, 2026

Derivation and characterization of ubiquitin-specific protease 18 inhibitorsBlessing O Ogunlade, Kevin N Dalby, Samuel C Okpechi, et al.

Scientific Reports|September 9, 2023

A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironmentCheng-Hsin Wei, Lu Huang, Blair Kreh, et al.

Molecular Cancer Therapeutics|December 5, 2020

A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid CancersMasanori Kawakami, Lisa Maria Mustachio, Yulong Chen, et al.

Pageof 14